Your browser doesn't support javascript.
loading
Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer's Disease in Rats.
Abd Elmaaboud, Maaly A; Estfanous, Remon S; Atef, Aliaa; Kabel, Ahmed M; Alnemari, Khalid A; Naguib, Tamer M; Alsufyani, Shuruq E; Darwish, Hany W; Arab, Hany H.
Afiliação
  • Abd Elmaaboud MA; Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
  • Estfanous RS; Anatomy and Embryology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
  • Atef A; Department of Pathology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
  • Kabel AM; Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
  • Alnemari KA; Taif Medical Center, Taif 26526, Saudi Arabia.
  • Naguib TM; Anesthesia and ICU Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
  • Alsufyani SE; Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
  • Darwish HW; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Arab HH; Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Pharmaceuticals (Basel) ; 16(10)2023 Sep 27.
Article em En | MEDLINE | ID: mdl-37895841

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article